Getagraph.com logo
S&P 500 Futures
(0.34%) 5 109.00 points
Dow Jones Futures
(0.71%) 38 653 points
Nasdaq Futures
(0.66%) 17 766 points
Oil
(0.16%) $79.08
Gas
(0.20%) $2.04
Gold
(-0.07%) $2 307.90
Silver
(-0.24%) $26.77
Platinum
(1.18%) $974.00
USD/EUR
(-0.15%) $0.931
USD/NOK
(-0.63%) $10.92
USD/GBP
(-0.22%) $0.796
USD/RUB
(0.50%) $91.59

Sanntidsoppdatering for Viridian Therapeutics, [VRDN]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-08)

Expected move: +/- 10.27%

BUY
60.00%
return 8.84%
SELL
40.00%
return 9.07%
Sist oppdatert2 mai 2024 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

5.58% $ 14.58

KJøP 113093 min ago

@ $18.37

Utstedt: 14 feb 2024 @ 20:55

Avkastning: -20.63%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: 1.83 %

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 22:00):
Profile picture for Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED...

Stats
Dagens volum 835 836
Gjennomsnittsvolum 907 181
Markedsverdi 930.53M
EPS $0 ( 2024-03-13 )
Neste inntjeningsdato ( $-1.070 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.75
ATR14 $0.0170 (0.12%)
Insider Trading
Date Person Action Amount type
2024-03-28 Fairmount Funds Management Llc Buy 5 859 Common Stock
2024-03-28 Fairmount Funds Management Llc Buy 21 999 Series A Non-Voting Convertible Preferred Stock
2024-03-28 Fairmount Funds Management Llc Sell 5 859 Common Stock
2024-03-28 Fairmount Funds Management Llc Sell 21 999 Series A Non-Voting Convertible Preferred Stock
2024-02-12 Tousignant Jennifer Buy 0
INSIDER POWER
58.81
Last 95 transactions
Buy: 5 352 885 | Sell: 1 550 540

Volum Korrelasjon

Lang: 0.05 (neutral)
Kort: 0.82 (strong)
Signal:(69.512) Same movement expected

Viridian Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
TBNK0.946
RGLD0.946
MCHI0.941
ISEM0.939
HCM0.938
IMVT0.938
QFIN0.935
PGJ0.933
WLFC0.932
ROIV0.924
10 Mest negative korrelasjoner
LLNW-0.934
PCRX-0.918
SFET-0.915
SWAV-0.913
ASPS-0.913
GRIN-0.907
NKTX-0.906
RTPY-0.895
LAWS-0.893
LNSR-0.889

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Viridian Therapeutics, Korrelasjon - Valuta/Råvare

The country flag 0.16
( neutral )
The country flag 0.04
( neutral )
The country flag 0.00
( neutral )
The country flag 0.14
( neutral )
The country flag -0.26
( neutral )
The country flag 0.40
( neutral )

Viridian Therapeutics, Økonomi

Annual 2023
Omsetning: $314 000
Bruttogevinst: $-1.01M (-321.02 %)
EPS: $-5.31
FY 2023
Omsetning: $314 000
Bruttogevinst: $-1.01M (-321.02 %)
EPS: $-5.31
FY 2022
Omsetning: $1.77M
Bruttogevinst: $1.02M (57.39 %)
EPS: $-3.91
FY 2021
Omsetning: $2.96M
Bruttogevinst: $0.00 (0.00 %)
EPS: $-6.66

Financial Reports:

No articles found.

Viridian Therapeutics,

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.